We are live on ! Find out more
IART icon

Integra LifeSciences

251 hedge funds and large institutions have $4.8B invested in Integra LifeSciences in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 83 increasing their positions, 92 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

40% more capital invested

Capital invested by funds: $3.43B → $4.8B (+$1.38B)

6% more funds holding

Funds holding: 237251 (+14)

1.68% more ownership

Funds ownership: 86.29%87.97% (+1.7%)

10% less repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 92

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

37% less call options, than puts

Call options by funds: $2.61M | Put options by funds: $4.13M

Holders
251
Holders Change
+14
Holders Change %
+5.91%
% of All Funds
4.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
31
Increased
83
Reduced
92
Closed
15
Calls
$2.61M
Puts
$4.13M
Net Calls
-$1.52M
Net Calls Change
-$1.86M
Name Holding Trade Value Shares
Change
Change in
Stake
Victory Capital Management
151
Victory Capital Management
Texas
$568K -$387K -7,194 -45%
Zurich Cantonal Bank
152
Zurich Cantonal Bank
Switzerland
$560K +$36.1K +670 +8%
OC
153
Oppenheimer & Co
New York
$559K +$36.9K +685 +9%
Osaic Holdings
154
Osaic Holdings
Arizona
$540K -$3.82K -71 -0.8%
MCC
155
Money Concepts Capital
Florida
$517K +$429K +7,966 New
Pacer Advisors
156
Pacer Advisors
Pennsylvania
$510K -$492K -9,142 -54%
PPCM
157
Pillar Pacific Capital Management
California
$481K
X
158
Xponance
Pennsylvania
$480K -$2.74K -51 -0.7%
LWM
159
Loveless Wealth Management
Montana
$472K -$14.8K -275 -4%
Assenagon Asset Management
160
Assenagon Asset Management
Luxembourg
$468K -$4.81M -89,473 -93%
IMRF
161
Illinois Municipal Retirement Fund
Illinois
$468K +$188K +3,489 +94%
N
162
Natixis
France
$454K +$377K +7,000 New
Commonwealth Equity Services
163
Commonwealth Equity Services
Massachusetts
$444K -$44.7K -831 -11%
ProShare Advisors
164
ProShare Advisors
Maryland
$442K +$43.7K +812 +14%
SAM
165
Securian Asset Management
Minnesota
$436K -$8.82K -164 -2%
Teacher Retirement System of Texas
166
Teacher Retirement System of Texas
Texas
$430K +$356K +6,624 New
GC
167
Guggenheim Capital
Illinois
$424K -$224K -4,161 -39%
ACM
168
AlphaCrest Capital Management
New York
$414K -$249K -4,633 -42%
GCP
169
GSA Capital Partners
United Kingdom
$413K +$17.1K +317 +5%
Deutsche Bank
170
Deutsche Bank
Germany
$408K -$3.66M -68,086 -92%
PAMU
171
Pictet Asset Management (UK)
United Kingdom
$403K
CGH
172
Crossmark Global Holdings
Texas
$401K -$9.69K -180 -3%
American Century Companies
173
American Century Companies
Missouri
$394K
BNP Paribas Financial Markets
174
BNP Paribas Financial Markets
France
$394K +$11.8K +220 +4%
QCM
175
Quantinno Capital Management
New York
$385K +$319K +5,925 New

IART Hedge Fund Activity: Q4 2020 in Review

251 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2020, worth a combined $4.8B — up 40% from $3.43B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new IART positions and 15 closed out — a net gain of 16 holders — while 83 added to existing stakes and 92 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $77.6M. The largest seller was Capital Research Global Investors, cutting an estimated $38.9M.

  • 251 institutional investors held Integra LifeSciences (IART) as of Q4 2020, up from 237 in Q3 2020.
  • Funds reported $4.8B of Integra LifeSciences stock for Q4 2020, up 40% quarter-over-quarter.
  • 31 funds opened new Integra LifeSciences positions in Q4 2020 and 15 closed out, a net change of +16 holders.
  • The largest Integra LifeSciences buyer in Q4 2020 was Wellington Management Group, an estimated $77.6M added.
  • The largest Integra LifeSciences seller in Q4 2020 was Capital Research Global Investors, an estimated $38.9M sold.

Based on aggregated 13F filings for Q4 2020.